| Market Capitalization (Millions $) |
1,957 |
| Shares
Outstanding (Millions) |
88 |
| Employees |
104 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-307 |
| Cash Flow (TTM) (Millions $) |
22 |
| Capital Exp. (TTM) (Millions $) |
4 |
Ideaya Biosciences Inc
Ideaya Biosciences Inc is a clinical-stage biotechnology company that focuses on the discovery and development of targeted therapeutics for patients with genomically defined cancers. The company utilizes its proprietary Synthetic Lethality Platform to identify and develop small molecules that can selectively target specific cancer-causing genetic alterations. By targeting these alterations, Ideaya aims to develop precise and effective treatments that can improve patient outcomes. The company is engaged in multiple clinical programs and collaborations with leading academic and pharmaceutical partners to advance its innovative pipeline of therapies.
Company Address: 5000 Shoreline Court South San Francisco 94080 CA
Company Phone Number: 443-6209 Stock Exchange / Ticker: NASDAQ IDYA
|
2.5% 